Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects

NCT01752881 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza vaccine (split virion, inactivated)
BIOLOGICAL: AdimFlu-S

Sponsor

Adimmune Corporation